Trials / Completed
CompletedNCT01473316
Study to Determine the Effect of Ketoconazole on the Pharmacokinetics of GDC-0980
An Open-Label, Fixed-Sequence, 2-Period Study to Determine the Effect of Ketoconazole on the Pharmacokinetics of GDC-0980
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Genentech, Inc. · Industry
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This will be an open-label, fixed-sequence, single-center, 2 period study. The study is designed to determine the effect of ketoconazole on the pharmacokinetics of GDC-0980.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GDC-0980 | Single oral dose |
| DRUG | Ketoconazole | Repeating Oral Dose |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2011-11-17
- Last updated
- 2016-11-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01473316. Inclusion in this directory is not an endorsement.